[Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
D000818:Animals; D001980:Bronchi / Q000187:drug effects*; D001993:Bronchodilator Agents / Q000494:pharmacology*; D004285:Dogs; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D006633:Histamine Antagonists / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D011460:Prostaglandins F / Q000037:antagonists & inhibitors*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
D001993:Bronchodilator Agents; D005768:Gastrointestinal Hormones; D006633:Histamine Antagonists; D011460:Prostaglandins F; D014660:Vasoactive Intestinal Peptide; D007545:Isoproterenol